IIM
BSX icon

Ivory Investment Management’s Boston Scientific BSX Stock Holding History

Ivory Investment Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-101,587
Closed -$1.37M – 102
2014
Q1 		$1.37M Sell
101,587
-108,516
-52% -$1.42M 0.06% 154
2013
Q4 		$2.52M Buy
210,103
+51,452
+32% +$608K 0.12% 97
2013
Q3 		$1.86M Sell
158,651
-4,640,028
-97% -$50.2M 0.09% 97
2013
Q2 		$44.5M Buy
+4,798,679
New +$40.7M 1.83% 14

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Ivory Investment Management's BSX Position: Q2 2014 in Review

Ivory Investment Management sold out of Boston Scientific (BSX) in Q2 2014, closing a stake of 101,587 shares — an estimated $1.37M sold.

Ivory Investment Management first reported a position in BSX in Q2 2013 and held it in 4 quarters. The position peaked at $44.5M in Q2 2013. 458 funds tracked by Wall St. Rank hold BSX as of Q2 2014.

  • Ivory Investment Management reported no remaining Boston Scientific position as of Q2 2014 after selling out during the quarter.
  • Ivory Investment Management sold 101,587 Boston Scientific shares in Q2 2014, an estimated $1.37M.
  • Ivory Investment Management first reported a position in Boston Scientific in Q2 2013 and held it in 4 quarters.
  • Ivory Investment Management's Boston Scientific position peaked at $44.5M in Q2 2013.
  • 458 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2014.

Based on Ivory Investment Management's 13F filing for Q2 2014, filed 13 Aug 2014.